References
Kelso, A.; MacDonald, H.R.: Precursor frequency analysis of lymphokine secreting alloreactive T lymphocytes. Dissociation of subsets producing interleukin 2, macrophage-activating factor, and granulocyte-macrophage colony-stimulating factor on the basis of Lyt-2 phenotype. J. exp. Med.156: 1366–1379(1982).
Miura, K.; Shimokawa, Y.; Honda, M.; Hayashi, H.: Lyt phenotype of lymphocytes producing murine macrophage chemotactic lymphokine. Cell. Immunol.75: 383–389 (1983).
Whitten, H.D.; Cruse, J.M.; Fudenberg, H.H.: Activation of macrophages by in vitro aUostimulated T ceils. Scand. J. Immunol.17: 335–343 (1983).
Guerne, P.A.; Piguet, P.F.; Vassalli, P.: Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after con A stimulation, in release of IL-2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production. J. Immun.130: 2225–2230 (1983).
Zlotnik, A.; Roberts, W.K.; Vasil, A.; Blumenthai, E.; LaRosa, F.; Leibson, H.J.; Endres, R.O.;Graham, S.D., Jr.; White, J.; Hill, J.; Henson, P.;Klein, J.R.; Bevan, M.J.; Marrack, P.; Kappler, J.W.: Coordinate production by a T cell hybridoma of gamma interferon and three other lym phokine activities: multiple activities of a single- lymphokine ? J. Immun.131: 794–800 (1983).
Higuchi, M.; Asada, M.; Kobayashi, Y.; Osawa, T.: Human T-cell hybridomas producing migration inhibitory factor and macrophage activating factors. Cell. Immunol.78: 257–265 (1983).
Le, J.; Vilchek, J.; Sadlik, J.R.; Cheung, M.K.; Balazs, I.; Sarngadharan, M.G.; Prensky, W.: Lymphokine production by human T cell hybridomas. J. Immun.130: 1231–1235 (1983).
Remold, H.G.; Mednis, A.; Kawaguchi, T.; Bersch, N.; Golde, D.W.: Production of migration inhibitory factor by a human T-lymphoblast cell line. Cell. Immunol.78: 305–313 (1983).
Yamamoto, S.; Leonard, E.J.; Meltzer, M.: Molecular weight, isoelectric point, and stability of a murine lymphokine that induces macrophage tumoricidal activity. J. reticuloendoth. Soc.33: 343–351 (1983).
Ramb, C.; Malorny, U.; Feige, U.; Sorg, C.: Characterization of human lymphocyte derived chemotactic factors for mononuclear phagocytes I. Pro- duction and detection. Molec. Immunol.20: 317- 324 (1983).
Ramb, C.; McEntire, J.E.; Sorg, C.: Characterization of human lymphocyte derived chemotactic factors for mononuclear phagocytes. II. Chemical characterization. Molec. Immunol.20: 325–332 (1983).
Geczy, C.L; Farram, E.; Moon, D.K.; Meyer, P.A.; McKenzie, I.F.: Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse. J. Immun.130: 2743–2749 (1983).
Farram, E.; Geczy, C.L.; Moon, D.K.; Hopper, K.: The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines. J. Immun.130: 2750–2756 (1983).
Helin, H.J.; Fox, R.I.; Edgington, T.S.: The instructor cell for the human procoagulant monocyte response to bacterial lipopolysaccharide is a Leu3a+ T cell by fluorescence-activated cell sorting. J. Immun.131: 749–752 (1983).
Steeg, P.S.; Moore, R.N.; Johnson, H.M.; Oppenhelm, J.J.: Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J. exp. Med.156: 1780–1793 (1982).
King, D.P.; Jones, P.P.: Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon. J. Immun.131: 315–318 (1983).
Wong, G.H.; Clark-Lewis, I.; McKimm-Bresch- kin, L.; Harris, A.W.; Schrader, J.W.: Interferon- gamma induces enhanced expression of la and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J. Immun.131: 788–793 (1983).
Steeg, P.S.; Johnson, H.M.; Oppenheim, J.J.: Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J. Immun.129: 2402–2406(1982).
Lu, C.Y.; Unanue, E.R.: Spontaneous T-cell lymphokine production and enhanced macrophage Ia expression and tumoilcidal activity in MRL-lpr mice. Clin. Immunol. Immunopathol.25:213–222 (1982).
Blumenthal, E.J.; Roberts, W.K.; Vasil, A.; Talmage, D.W.: Macrophage activation: dissociation of cytotoxic activity from Ia-A antigen expression. Proc. natn. Acad. Sci. USA80: 2031–2035 (1983).
Guyre, P.M.; Morganelli, P.M.; Miller, R.: Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mono- nuclear phagocytes. J. clin. Invest.72: 393–397 (1983).
Moscicki, R.A.; Amento, E.P.; Krane, S.M.; Kurnick, J.T.; Colvin, R.B.: Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. J. Immun.131: 743- 748 (1983).
Foils, G.; Hauck, M.; Dezso, B.; Medgyesi, G.A.; Fust, G.: Effect of low molecular weight lymphokine components on the Fc and C3b receptor- mediated macrophage functions: Cell. Immunol.78: 276–284(1983).
Coleman, D.L.; Root, R.K.; Ryan, J.L.: Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat- stable lymphokine. J. Immun.130: 2195–2199 (1983).
Clement, L.T.; Lehmeyer, J.E.: Regulation of the growth and differentiation of a human monocytic cell line by lymphokines. I. Induction of superox- ide anion production and chemiluminescence. J. Immun.130: 2763–2766 (1983).
Onozaki, K.; Akagawa, K.S.; Haga, S.; Miura, K.; Hashimoto, T.; Tokunaga, T.: Role of lymphokines in regulation of macrophage differentiation. Cell. Immunol.76: 129–136 (1983).
Meltzer, M.S.; Benjamin, W.R.; Farrar, J.J.: Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line. J. Immun.129: 2802–2807 (1982).
Nacy, C.A.; James, S.L.; Benjamin, W.R.; Farrar, J.J.; Hockmeyer, W.T.; Meltzer, M.S.: Activation of macrophages for microbicidal and tumoilcidal effector functions by soluble factors from EL-4, a continuous T cell line. Infect. Immunity40: 820- 824(1983).
Gemsa, D.; Debatin, K.M.; Kramer, W.; Kubelka, C.; Deimann, W.; Kees, U.; Krammer, P.H.: Macrophage-activating factors from different T cell clones induce distinct macrophage functions. J. Immun.131: 833–844 (1983).
Tabor, D.R.; Saluk, P.H.: Differential activation of resident macrophage subsets with two sources of lymphokine preparations. Infect. Immunity40: 177–183(1983).
Johnson, W.J.; Marino, P.A.; Schreiber, R.D.; Adams, D.O.: Sequential activation of murine mono-nuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development. J. Immun.131: 1038- 1043 (1983).
Dean, R.T.; Virelizier, J.L.: Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals. Clin. exp. Immunol.51: 501–510 (1983).
Fischer, D.G.; Golightly, M.G.; Koren, H.S.: Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon. J. Immun.130: 1220–1225 (1983).
Arenzana-Seisdedos, F.; Virelizier, J.L.: Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysac- charide-stimulated human monocytes. Eur. J. Immunol.13:437–440(1983).
Wisseman, C.L., Jr.; Waddell, A.: Interferon-like factors from antigen and mitogen-stimulated human leukocytes with antiilckettsial and cytolytic actions onRickettsia pronazekii infected human endothelial cells, fibroblasts, and macrophages. J. exp. Med.157: 1780–1793 (1983).
Pace, J.L.; Russell, S.W.; Tortes, B.A.; Johnson, H.M.; Gray, P.W.: Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J. Immun.130: 2011–2013 (1983).
Pace, J.L.; Russell, S.W.; Schreiber, R.D.; Altman, A.; Katz, D.H.: Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc. natn. Acad. Sci. USA80: 3782–3786(1983).
Mannel, D.N.; Falk, W.: Interferon gamma is required in activation of macrophages for tumor cytotoxicity. Cell. Immunol.79: 396–402 (1983).
Schreiber, R.D.; Pace, J.L.; Russell, S.W.; Altman, A.; Katz, D.H.: Macrophage activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. J. Immun.131: 826–832 (1983).
Nathan, C.F.; Murray, H.W.; Wiebe, M.E.; Rubin, B.Y.: Identification of interferon-7 as the lympho- kine that activates human macrophage oxidative metabolism and antimicrobial activity. J. exp. Med.158: 670–689 (1983).
Kleinerman, E.S.; Schroit, A.J.; Fogler, W.E.; Fidler, I.J.: Tumoricidal activity of human monocytes activated in vitro by free and liposome- encapsulated human lymphokines. J. clin. Invest.72:304–315(1983).
Pidgeon, C.; Schreiber, R.D.; Schultz, R.M.: Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes. J. Immun.131: 311–314 (1983).
Ralph, P.; Nacy, C.A.; Meltzer, M.S.; Williams, N.; Nakoinz, I.; Leonard, E.J.: Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities. Cell. Immunol.76: 10–21 (1983).
James, S.L.; Leonard, E.J.; Meltzer, M.S.: Macrophages as effector cells of protective immunity in murine Schistosomiasis. IV. Coincident induction of macrophage activation for extracellular killing of schistosomula and tumor cells. Cell. Immunol.74: 86–96 (1982).
James, S.L.; Skamene, E.; Meltzer, M.S.: Macrophages as effector cells of protective immunity in murine Schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection. J. Immun.131: 948–953 (1983).
Byrne, G.I.; Faubion, C.L.: Inhibition ofChlamy diapsittaci in oxidatively active thioglycolate-elicited macrohages: distinction between lymphokine- mediated oxygen-dependent and oxygen-independent macrophage activation. Infect. Immunity40: 464–471 (1983).
Murray, H.W.; Byrne, G.I.; Rothermel, C.D.; Cartelli, D.M.: Lymphokine enhances oxygen-independent activity against intracellular pathogens. J. exp. Med.158: 234–239 (1983).
Murray, H.W.; Cartelli, D.M.: Killing of intracellularLeishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. J. clin. Invest.72:32–44(1983).
Nacy, C.A.; Fortier, A.H.; Pappas, M.G.; Henry, R.R.: Susceptibility of inbred mice toLeishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities. Cell. Immunol.77: 298–307 (1983).
Nakagawara, A.; Desantis, N.M.; Nogueira, N.; Nathan, C.F.: Lymphokines enhance the capacity of human monocytes to secrete reactive oxygen intermediates. J. clin. Invest.70: 1042–1048 (1982).
Beaman, L.; Benjamini, E.; Pappagianis, D.: Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing ofCoccidioides immitis. Infect. Immunity39: 1201–1207 (1983).
Leu, R.W.; Hefley, S.M.; Herriott, M.J.: Decreased Fc and C3 receptor function in macrophage populations which are refractory to migration inhibitory factor, C3 activators, and immune complex. Cell. lmmunol.80: 31–42 (1983).
Homma, Y.; Onozaki, K.; Fukutomi, Y.; Hashimoto, T.: The mechanism of cell surface changes of guinea pig macrophages activated with purified migration inhibitory factor/macrophage activation factor. Cell. Immunol.72: 231–238 (1982).
Tushinski, R.J.; Stanley, E.R.: The regulation of macrophage protein turnover by a colony stimulating factor (CSF-1). J. cell. Physiol.116: 67–75 (1983).
Chen, B.D.; Hsu, S.; Lin, H.S.: Binding, internalization and degradation of colony-stimulating factor by peritoneal exudate macrophages. Biochim. biophys. Acta721: 366–373 (1982).
Guilbert, L.J.; Nelson, D.J.; Hamilton, J.A.; Williams, N.: The nature of 12-O-tetradecanoylphor- bol-13-acetate (TPA)-stimulated hemopoiesis, col- ony-stimulating factor (CSF) requirement for colony formation, and the effect of TPA on (125I)CSF- 1 binding to macrophages. J. cell. Physiol.115: 276–282 (1983).
Chen, B.D.; Lin, H.S.; Hsu, S.: Tumor-promoting phorbol esters inhibit the binding of colony-stimulating factor (CSF-1) to murine peritoneal exudate macrophages. J. cell. Physiol.116: 207–212 (1983).
Chen, B.D.; Lin, H.S.; Hsu, S.: Lipopolysaccharide inhibits the binding of colony-stimulating factor (CSD-1) to murine peritoneal exudate macrophages. J. Immun.130: 2256–2260 (1983).
Abe, E.; Miyaura, C.; Tanaka, H.; Shiina, Y.; Kuribayashi, T.; Suda, S.; Nishii, Y.; DeLuca, H.F.; Suda, T.: la,25-Dihydroxy-vitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell mediated indirect mechanism. Proc. natn. Acad. Sci. USA80: 5583–5587 (1983).
Wilkins, J.A.; Sigurdson, L.; Jordon, Y.; Rutherford, W.J.; Warrington, R.J.: Immunoregulatory factors from a human macrophage-like cell line. II. A human T-cell lymphokine-induced suppressor factor for lymphocyte proliferation. Cell. Immunol.77:329–337(1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, D.Y. Macrophage-directed lymphokines. Surv. immunol. Res. 3, 154–160 (1984). https://doi.org/10.1007/BF02918783
Issue Date:
DOI: https://doi.org/10.1007/BF02918783